Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib with FOLFOX in Metastatic Colorectal Cancer
NCT00049101Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Aug 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in colorectal cancer (CRC), sponsored by Memorial Sloan Kettering Cancer Center. Started Aug 2002; status: completed.
02
Drugs
erlotinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00049101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00049101.